Belluscura (BELL.L) Stock Price
£0.75 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Belluscura, AI stock picks, stock alerts and much more.
BELL.L AI Stock Analysis
AI stock analysis for BELL.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Belluscura (BELL.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Belluscura (BELL.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Belluscura (BELL.L), currently trading at £0.75, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BELL.L
-
Belluscura plc develops and commercialize oxygen related medical device products.
-
Symbol
BELL.L
-
Market
LSE
-
Industry
Medical - Devices
-
Market Cap
3M
Similar Stocks
 |
Creo Medical Limited CREO.L |
£12.75 0.00% |
5 |
 |
MaxCyte MXCT.L |
£147.7 7.7% |
5 |
 |
Smith & Nephew SN.L |
£1111.5 0.4% |
7 |
 |
Novacyt S.A. NCYT.L |
£41.45 1.7% |
4 |
 |
Surgical Innovations Group SUN.L |
£0.7 6.9% |
5 |
News
BELL.L Alternative Data
Web Traffic
Belluscura receives an estimated 1788 monthly visitors to belluscura.com.
-
Web Traffic
1788
-
Change from Previous Month
139.4%
-
3 Month Change
318.7%
-
YoY Change
318.7%
Facebook Engagement
Belluscura has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Youtube Subscribers
Belluscura has 119 subscribers on its main Youtube channel, up by 0.8% over the last month.
-
Youtube Subscribers
119
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
2.6%
-
YoY Change
2.6%
Job Postings
Belluscura currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Twitter Followers
Belluscura has 276 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
276
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Instagram Followers
Belluscura has 22 Instagram Followers on its main Instagram account.
-
Instagram Followers
22
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
8.3%
-
YoY Change
8.3%
LinkedIn Followers
1,253 are following Belluscura on LinkedIn, up by 1% over the last month.
-
LinkedIn Followers
1253
-
Daily Change
1%
-
1 Month Change
1%
-
3 Month Change
1.5%
-
YoY Change
1.5%
LinkedIn Employees
According to LinkedIn, Belluscura has 31 employees, down by -3.1% over the last month.
-
LinkedIn Employees
31
-
Daily Change
3.1%
-
1 Month Change
3.1%
-
3 Month Change
3.1%
-
YoY Change
3.1%
News Mentions
Belluscura was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Belluscura has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
BELL.L Financials
BELL.L Key Metrics
-
Total Revenue
$672.9K
-
Net Income
-$3.3M
-
Earnings per Share
-$0.0205
-
Free cash flow
-$2.7M
-
EBITDA
-$3M
-
EBITDA Ratio
-4.45313
-
Total Assets
$21.5M
BELL.L 2-year Revenue & Income
BELL.L 2-year Free Cash Flow
BELL.L Technicals
BELL.L SMA
BELL.L RSI
FAQ
What's the current price of Belluscura (BELL.L) Stock?
The price of an Belluscura (BELL.L) share is £0.75.
What's the market cap of Belluscura?
The current market cap of Belluscura is 3M.
Should I buy or sell BELL.L?
Belluscura shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Belluscura is better viewed as a hold or accumulate position while waiting for further developments.
Is Belluscura a good investment?
The current analysis of Belluscura's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Belluscura's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Belluscura (BELL.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Belluscura stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Belluscura (BELL.L) that investors often compare it to?
Belluscura (BELL.L) is often compared to similar stocks such as Creo Medical Limited, MaxCyte, Smith & Nephew, Novacyt S.A. and Surgical Innovations Group.
What is the forecast for Belluscura's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Belluscura's stock price to be around £0.731 in 2026. Starting from the current price of £0.75, this represents a 2.5% change in price, indicating a neutral outlook for the stock.
How to buy Belluscura (BELL.L) Stock?
Belluscura stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Belluscura shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.